Fan Lin, Wang Pengyang, He Chang, Chen Xiaoyu, Dai Linlong, Xiong Daokai, Zhong Guofu
Department of Chemistry, Eastern Institute of Technology Ningbo Zhejiang 315200 China
Chem Sci. 2025 Sep 1. doi: 10.1039/d5sc05468k.
Enhancing drug efficacy often involves increasing the proportion of sp-hybridized carbons. Three-dimensional polycyclic frameworks, such as bicyclo[1.1.1]pentanes (BCPs) and bicyclo[2.1.1]hexanes (BCHs), serve as excellent benzene bioisosteres, improving bioavailability and reducing toxicity while retaining biological activity. However, synthetic routes to 2D/3D-ring-fused BCHs dearomatization are scarce, previously limited to cycloadditions of bicyclobutanes (BCBs) with indoles, bicyclic aza-arenes, or naphthalenes. Herein, we achieve Lewis acid-catalyzed dearomatization of BCBs with 2-naphthol. Eu(OTf) catalysis provides dearomatized tertiary alcohols, while AgBF promotes dearomatization/aromatization to directly access naphthalene-fused BCHs, showcasing remarkable reaction selectivity. Mechanistic studies definitively identify cyclobutyl carbocations as key intermediates. This strategy is anticipated to accelerate the exploration of fused BCH scaffolds in medicinal and synthetic chemistry.
提高药物疗效通常涉及增加sp杂化碳的比例。三维多环骨架,如双环[1.1.1]戊烷(BCP)和双环[2.1.1]己烷(BCH),可作为出色的苯生物电子等排体,在保留生物活性的同时提高生物利用度并降低毒性。然而,二维/三维环稠合BCH脱芳构化的合成路线很少,以前仅限于双环丁烷(BCB)与吲哚、双环氮杂芳烃或萘的环加成反应。在此,我们实现了BCB与2-萘酚的路易斯酸催化脱芳构化反应。Eu(OTf)催化提供脱芳构化的叔醇,而AgBF促进脱芳构化/芳构化以直接获得萘稠合的BCH,展示出显著的反应选择性。机理研究明确确定环丁基碳正离子为关键中间体。预计该策略将加速在药物化学和合成化学中对稠合BCH支架的探索。